Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Siliphos is a patented dietary supplement and botanical extract that combines silybin (the most active flavonoid from milk thistle, Silybum marianum) with phospholipids (phosphatidylcholine) to form a highly bioavailable complex. This formulation significantly enhances the absorption and bioavailability of silybin compared to standard milk thistle or silymarin extracts. The primary mechanism of action is antioxidant activity—neutralizing free radicals and protecting liver cells from oxidative stress—and supporting detoxification processes in the liver. Siliphos also stimulates protein synthesis in hepatocytes and helps maintain normal levels of glutathione, contributing to overall liver health. It is primarily used for liver support but has also been marketed as a natural alternative to retinoids for skin health due to its effects on collagen production and wrinkle reduction[1][2][3][4][5][6][8][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Siliphos.